Effects of an Exercise and Diet Program on Biochemistry and Body Composition in Patients With CKD in G1 and G2 Stages
NCT ID: NCT06912425
Last Updated: 2025-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
15 participants
INTERVENTIONAL
2024-10-01
2025-10-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise for Chronic Kidney Diseases
NCT04522115
Physical Exercise With Flow Restriction of the Forearm in Chronic Kidney Disease
NCT02619968
The Effects of Exercise in End-stage Renal Disease Patients Undergoing Hemodialysis
NCT02621918
Exercise in Obese Diabetic Patients With Chronic Kidney Disease
NCT01036490
Physical Activity and Functioning in Home Dialysis Patients
NCT01602718
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supervised Exercise Intervention Group
This group will be assigned a personalized exercise program designed by the researchers, specialists in kidney disease training. Participants will be assigned to the supervised exercise intervention through a randomization process, ensuring a homogeneous sample
Health prevention.
Unlike other projects, this study focuses on an underexplored area in exercise and kidney disease research. Typically, exercise recommendations are directed toward individuals undergoing hemodialysis or peritoneal dialysis. However, in the early stages of the disease, when the kidneys begin to show alterations, there is no established safe training protocol as a preventive measure. This clinical trial will fill that gap by providing references for an exercise program specifically designed for individuals in the early stages of kidney disease. The main objective will be to compare two different exercise strategies to determine potential benefits for renal health.
Exercise Based on KDIGO Recommendations
To this group will be assigned KDIGO exercise.
This group will be assigned exercise based on KDIGO recommendations. They will be provided with an exercise template according to KDIGO guidelines, without further exercise planning. Additionally, they will receive a protein-controlled diet along with an educational intervention.
Health prevention.
Unlike other projects, this study focuses on an underexplored area in exercise and kidney disease research. Typically, exercise recommendations are directed toward individuals undergoing hemodialysis or peritoneal dialysis. However, in the early stages of the disease, when the kidneys begin to show alterations, there is no established safe training protocol as a preventive measure. This clinical trial will fill that gap by providing references for an exercise program specifically designed for individuals in the early stages of kidney disease. The main objective will be to compare two different exercise strategies to determine potential benefits for renal health.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health prevention.
Unlike other projects, this study focuses on an underexplored area in exercise and kidney disease research. Typically, exercise recommendations are directed toward individuals undergoing hemodialysis or peritoneal dialysis. However, in the early stages of the disease, when the kidneys begin to show alterations, there is no established safe training protocol as a preventive measure. This clinical trial will fill that gap by providing references for an exercise program specifically designed for individuals in the early stages of kidney disease. The main objective will be to compare two different exercise strategies to determine potential benefits for renal health.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Who meet the requirements of normal or decreased filtration rate according to:
* G1: ≥ 90 or G2: 60-89 mL/ min/ 1.73m2
* Alterations in the urinary sediment (cellular cylinders of any type, dysmorphic erythrocytes).
* Confirmation of damage by renal ultrasound (Decreased renal size, thinning of the renal cortex, increased echogenicity of the parenchyma, poor differentiation between the renal cortex and sinus, renal cysts suggestive of cortical or medullary changes).
* Men and women between 18 and 65 years old
* Control of baseline pathologies (glycosylated hemoglobin less than 9%, blood pressure no higher than 140/90mmHg).
* Patients who agree to participate in the study and sign the informed consent form.
* Patients who have no limitations to perform the exercises.
* If participants have diagnosed diabetes or hypertension, who are on medication and under regular internal medicine or nephrology treatment.
* Male and female patients, including those who are illiterate but can be accompanied in the initial sessions to sign the informed consent form.
* All participants, even those who do not have a mobile device, will be provided with an exercise and nutrition guide so that they do not have any limitations when carrying out the activities.
Exclusion Criteria
* Children under 18 years of age
* Patients who, due to their place of origin, find it difficult to travel to the sessions.
* Diabetes Mellitus in uncontrolled (Glycated Hemoglobin \>9 %)
* Those who have lost their sight
* Presence of uremic alterations such as uremic encephalopathy.
* Who present unstable blood pressure with blood pressure levels above 140/90mmHg, patients showing sustained blood pressure elevations above 140/90 will be discontinued from the study.
* Peripheral vascular disease of all types (Peripheral Arterial Disease (PAD), Deep Vein Thrombosis (DVT), Chronic Venous Disease (CVD), Abdominal Aortic Aneurysm (AAA), Buerger's Phenomenon (Thromboangiitis Obliterans), Kawasaki Disease).
* Failure to sign the informed consent form
Elimination Criteria:
* Injury, discomfort that makes reincorporation impossible.
* Patients who have decided to abandon the study
* Patients who do not attend 2 of the face-to-face sessions, those who do not attend two of their sessions will be taken into consideration.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Guadalajara
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana Patricia Zepeda Salvador
Effects of an Exercise and Diet Program on Biochemistry and Body Composition in Patients With CKD in G1 and G2 Stages
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Universitario del Sur
Ciudad Guzmán, Jalisco, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Ash S, Campbell KL, Bogard J, Millichamp A. Nutrition prescription to achieve positive outcomes in chronic kidney disease: a systematic review. Nutrients. 2014 Jan 22;6(1):416-51. doi: 10.3390/nu6010416.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGAF2024/2
Identifier Type: OTHER
Identifier Source: secondary_id
97/HRCG-JAL/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.